Developing vaccines for infectious diseases and biodefense
Official title: Development of Therapeutic Candidates for Biodefense, Infections and Emerging Infectious Diseases
Funded at Access to Advanced Health Institute · NIH-11127346 · Data updated 2026-11-12
This study is working on developing new vaccines to protect people from infectious diseases that could come from natural outbreaks or intentional releases, and it's testing these vaccines in animals to make sure they're safe and effective before they can be used in humans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Access to Advanced Health Institute NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | July 5, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $3,781,845 |
| NIH project number | 75N93023C00018-P00003-9999-1 |
| Project ID | NIH-11127346 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals at risk of exposure to emerging infectious diseases or those in need of new vaccine options.
✕Less likely to help
Patients who are not at risk for infectious diseases or who have existing effective vaccines may not receive benefit from this research.
What this research studies
This research focuses on creating and testing vaccines for infectious diseases that may arise from natural outbreaks or intentional releases. It involves formulating vaccine components and conducting various tests in animal models to ensure their safety and effectiveness. The research aims to advance these candidates through the necessary regulatory processes to eventually evaluate their safety and efficacy in humans. Patients may benefit from the development of new vaccines that could protect against emerging infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from serious infectious diseases.
How similar studies have gone: Previous research has shown success in developing vaccines for infectious diseases using similar approaches, indicating a promising path forward.
Where this research is happening
-
Access to Advanced Health Institute
Seattle, United States Active
Researchers
- Principal investigator: Voigt, Emily — Access to Advanced Health Institute
- Study coordinator: Voigt, Emily
Related research
Other NIH-funded projects on the same topics.
-
Developing a vaccine to prevent Entamoeba histolytica infections
This study is working on a new vaccine to help protect people from a parasite that can cause serious stomach problems, and if it works well, it could be especially helpful for those living in places where these infections are more common.
-
Developing vaccines for biodefense and emerging infectious diseases
This study is working on new vaccines to help protect people from serious infections that could come from natural outbreaks or intentional releases, and it aims to make sure these vaccines are safe and effective for everyone.
-
Developing a vaccine to prevent Entamoeba histolytica infections
This study is working on a new nasal vaccine to help protect people from a parasite that causes serious stomach issues, and if it works well in tests, it could offer a new way to prevent these infections in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.